Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet

NCT01072669 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Ischemia

Interventions

DRUG: ambrisentan

Sponsor

Soumya Chatterjee

Collaborators

[object Object]